Medicine News and Research

RSS

Researchers identify cells responsible for cardiac damage repair after infarction

Researchers at Cima and the Clinica Universidad de Navarra (Spain) have led an international study identifying the cardiac cells responsible for repairing the damage to this organ after infarction.

29 Sep 2020

‘No Mercy’ explores the fallout after a small town loses its hospital

Midwesterners aren’t known for complaining. But after Mercy Hospital Fort Scott closed, hardship trickled down to people whose lives were already hard.

29 Sep 2020

Corralling the facts on herd immunity

For a term that's at least 100 years old, "herd immunity" has gained new life in 2020.

29 Sep 2020

Computer model unravels mystery behind severe inflammation in people with COVID-19

A study from the University of Pittsburgh School of Medicine and Cedars-Sinai addresses a mystery first raised in March: Why do some people with COVID-19 develop severe inflammation?

29 Sep 2020

Jellagen announces collaboration with Mayo Clinic

Jellagen has entered into a license agreement for an exclusive grant to patent rights with Mayo Clinic for the development in treatment of vocal cord paralysis.

29 Sep 2020

Girls participating in sports show improved behavior, attentiveness in early adolescence

Girls - but not boys - who participate actively in school sports activities in middle childhood show improved behavior and attentiveness in early adolescence, suggests a new Canadian study published in Preventative Medicine.

29 Sep 2020

WHO offers guideline on managing pharmaceutical prices

Unaffordable prices can be one of the biggest barriers to access to pharmaceutical products. A new WHO guideline for countries on managing pharmaceutical prices aims to help governments overcome this barrier and better address national public health needs.

29 Sep 2020

Antibody improves progression-free survival in patients with advanced prostate cancer

An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant prostate cancer.

29 Sep 2020

Phase 1 trial of new class of drugs shows promise in range of advanced cancers

A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial - highlighting the potential of a new class of drugs known as ATR inhibitors.

29 Sep 2020

Observation offers a better understanding of how neurons communicate with each other

The dialogue between neurons is of critical importance for all nervous system activities, from breathing to sensing, thinking to running. Yet neuronal communication is so fast, and at such a small scale, that it is exceedingly difficult to explain precisely how it occurs.

29 Sep 2020

Study identifies thousands of deaths caused by heart disease and stroke during COVID-19 pandemic

A major new study has identified 2085 excess deaths in England and Wales due to heart disease and stroke during the peak of the COVID-19 pandemic. On average, that is 17 deaths each day over four months that probably could have been prevented.

29 Sep 2020

ACS quality program demonstrates the importance of overall hospital culture of quality and safety

Hospital resources and infrastructure dedicated to improving quality and safety are essential for achieving safe and high-quality surgical outcomes.

29 Sep 2020

Specific anti-bacterial T cells are strongly activated in people with moderate to severe COVID-19

A type of anti-bacterial T cells, so-called MAIT cells, are strongly activated in people with moderate to severe COVID-19 disease, according to a study by researchers at Karolinska Institutet in Sweden that is published in the journal Science Immunology. The findings contribute to increased understanding about how our immune system responds against COVID-19 infection.

29 Sep 2020

Combined study results present a strong case for lung cancer screening in New Zealand

Newly released study results present a strong case for lung cancer screening in New Zealand - particularly for Māori whose mortality rates are between three and four times higher than other ethnic groups.

29 Sep 2020

A special issue on the emerging COVID-19 infection

Acta Pharmaceutica Sinica B publishes special issue on 'Research on Emerging COVID-19 (Target, Mechanism, and Therapeutics)' edited by Hai-Bin Luo, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China; Shilin Chen, Institute of Chinese Materia Medica, Beijing, China and Peiqing Liu, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, China.

29 Sep 2020

Study shows how Zika virus degrades key protein involved in neurological growth

In a study published in Autophagy, researchers at the University of Maryland (UMD) shed new light on how Zika virus hijacks our own cellular machinery to break down a protein that is essential for neurological development and cellular communication, getting it to "eat itself."

29 Sep 2020

ACD study underscores the prevalence of malnutrition among obese individuals

A new editorial accompanying a study published in the Journal of the American College of Cardiology is bringing attention to the underappreciated and often overlooked issue of malnutrition among those who are obese.

29 Sep 2020

Antiacid monotherapy is better than combination therapy in relieving epigastric pain

Antacid monotherapy is more effective in relieving epigastric pain than in combination with lidocaine. That is the conclusion of a study to be published in the September 2020 issue of Academic Emergency Medicine (AEM), a journal of the Society for Academic Emergency Medicine (SAEM).

29 Sep 2020

MU researchers identify mutations in virus causing COVID-19

When Saathvik Kannan's father, a faculty member at the University of Missouri, saw his friend, Kamlendra Singh, a research professor at MU, on television being interviewed for his research identifying possible treatments for COVID-19, he called Singh to congratulate him on his work.

29 Sep 2020

Cincinnati Children's research leads to approval of new drug for hypereosinophilic syndrome

Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children's Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) for use in the treatment of patients with hypereosinophilic syndrome.

28 Sep 2020

Medicine News and Research

Researchers identify cells responsible for cardiac damage repair after infarction

‘No Mercy’ explores the fallout after a small town loses its hospital

Corralling the facts on herd immunity

Computer model unravels mystery behind severe inflammation in people with COVID-19

Jellagen announces collaboration with Mayo Clinic

Girls participating in sports show improved behavior, attentiveness in early adolescence

WHO offers guideline on managing pharmaceutical prices

Antibody improves progression-free survival in patients with advanced prostate cancer

Phase 1 trial of new class of drugs shows promise in range of advanced cancers

Observation offers a better understanding of how neurons communicate with each other

Study identifies thousands of deaths caused by heart disease and stroke during COVID-19 pandemic

ACS quality program demonstrates the importance of overall hospital culture of quality and safety

Specific anti-bacterial T cells are strongly activated in people with moderate to severe COVID-19

Combined study results present a strong case for lung cancer screening in New Zealand

A special issue on the emerging COVID-19 infection

Study shows how Zika virus degrades key protein involved in neurological growth

ACD study underscores the prevalence of malnutrition among obese individuals

Antiacid monotherapy is better than combination therapy in relieving epigastric pain

MU researchers identify mutations in virus causing COVID-19

Cincinnati Children's research leads to approval of new drug for hypereosinophilic syndrome

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News